sist for several days and then recur after 2-3 weeks. He also complained of severe bouts of arthralgia and severe earache. He received antibiotic treatment and a long trial of aspirin therapy for suspected juvenile rheumatoid arthritis, without improvement. When first examined by us at the age of 3 years, we noted pain in the TMJ, which subsided in 4 days. The history of recurrent fever and recurrent TMJ arthritis was suggestive of FMF. After excluding other rheumatic diseases, he received colchicine 0.5 mg twice dally. He has been asymptomatic for 1 year since the initiation of this treatment.
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Sir: The Australian NHMRC Twin Registry contains over 4000 pairs of twins under 10 years old and a further 3000 up to the age of 18 years. The parents of these twins have volunteered to consider requests from researchers for studies in bona fide projects approved by the Registry. This represents a major resource for studies in paediatric and adolescent epidemiology.
There are numerous and ingenious ways in which twins can be used to address scientific and medical questions. Some examples include examining genetic and environmental causes of variation, co-twin control studies based on disease discordant or exposure discordant pairs, longitudinal studies, and studies of gene-environment interaction.
Although there have been over 70 projects conducted over the last 12 years on the 17000 adult pairs on the Registry, to date there have been few studies making use of the younger pairs. Baseline information has been computerised on about 50% of these pairs.
I would like to bring this to the attention of international paediatric researchers. Applications to utilise the Registry can be made from researchers throughout the world. There may be some charge, depending on costs and the level of work required by local staff. All applications are reviewed by the Executive Committee of the Registry, and advice on study design and practicalities is available. For more information, please write to me at the address above.
